How are thyroid and HPA signaling linked?

Thyroid and hypothalamic–pituitary–adrenal (HPA) signaling are bidirectionally linked in humans. The interaction is clinically relevant when interpreting thyroid tests, cortisol measurements, or symptoms during overt thyroid dysfunction, exogenous glucocorticoid treatment, or endogenous cortisol excess.

Clinical and kinetic evidence

• Thyroid status alters cortisol kinetics. Hyperthyroidism is associated with increased cortisol metabolic clearance, a shorter cortisol half-life, and increased cortisol production; these measures move toward euthyroid values after treatment. Increased production may compensate for faster disposal rather than indicating sustained cortisol excess.
• Hypothyroidism produces the opposite clearance pattern: prolonged cortisol half-life and higher mean cortisol, consistent with reduced clearance. Twenty-four-hour cortisol production may remain normal or decrease, so effects on production are state-dependent rather than uniformly directional.
• Glucocorticoids suppress TSH regulation. In healthy participants given dexamethasone 16 mg/day for 2.5 days, basal TSH fell from 2.2 to 0.8 μU/mL, with markedly reduced TRH-stimulated secretion. Suppression can occur within 8–12 hours. In Cushing syndrome, impaired TRH-stimulated TSH responses improve after treating cortisol excess.

Mechanistic interpretation

• Dexamethasone lowers serum T3/free T3 while T4 remains unchanged and can raise reverse T3, consistent with altered peripheral T4 handling—potentially less T4-to-T3 activation and/or greater inactivation. Human studies infer this from circulating hormone patterns rather than tissue deiodinase measurements.
• Thyroid state also changes cortisol-binding globulin: higher in hypothyroidism and lower in hyperthyroidism. Thus, total cortisol may not directly reflect free cortisol, production, or clearance.

Bottom line

• The claim is supported: thyroid dysfunction changes cortisol production and, more consistently, clearance; glucocorticoid excess or treatment can suppress TSH and shift peripheral thyroid-hormone metabolism toward lower T3 and sometimes higher reverse T3. Interpretation should account for thyroid state, glucocorticoid exposure, timing, and binding-protein effects.